ATE286402T1 - Verwendung von morinda citrifolia zur behandlung von tinnitus - Google Patents
Verwendung von morinda citrifolia zur behandlung von tinnitusInfo
- Publication number
- ATE286402T1 ATE286402T1 AT01912627T AT01912627T ATE286402T1 AT E286402 T1 ATE286402 T1 AT E286402T1 AT 01912627 T AT01912627 T AT 01912627T AT 01912627 T AT01912627 T AT 01912627T AT E286402 T1 ATE286402 T1 AT E286402T1
- Authority
- AT
- Austria
- Prior art keywords
- medicament
- extract
- morinda citrifolia
- leaves
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000698A SE516468C2 (sv) | 2000-03-02 | 2000-03-02 | Användning av ett extrakt från Morinda citrifolia L. för framställning av läkemedel för behandling av tinnitus. |
PCT/SE2001/000447 WO2001064231A1 (en) | 2000-03-02 | 2001-03-02 | Use of a composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE286402T1 true ATE286402T1 (de) | 2005-01-15 |
Family
ID=20278673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01912627T ATE286402T1 (de) | 2000-03-02 | 2001-03-02 | Verwendung von morinda citrifolia zur behandlung von tinnitus |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1261358B1 (de) |
AT (1) | ATE286402T1 (de) |
AU (1) | AU2001241315A1 (de) |
DE (1) | DE60108227D1 (de) |
SE (1) | SE516468C2 (de) |
WO (1) | WO2001064231A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6737089B2 (en) * | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
US8652546B2 (en) | 2007-09-06 | 2014-02-18 | Tahitian Noni International, Inc. | Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals |
US7244463B2 (en) | 2005-10-18 | 2007-07-17 | Tahitian Noni International, Inc. | Garcinia mangostana L. enhanced animal food product |
US8790727B2 (en) | 2000-12-05 | 2014-07-29 | Tahitian Noni International, Inc. | Morinda citrifolia and iridoid based formulations |
US8574642B2 (en) | 2000-12-05 | 2013-11-05 | Tahitian Noni International, Inc. | Antiviral Morinda citrifolia L. based formulations and methods of administration |
US7442395B2 (en) | 2002-11-14 | 2008-10-28 | Tahitian Noni International, Inc. | Formulation for treating candidiasis using Morinda citrifolia |
US8025910B2 (en) | 2006-05-12 | 2011-09-27 | Tahitian Noni International, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
US8535741B2 (en) | 2006-05-12 | 2013-09-17 | Morinda, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
EP4299059A1 (de) | 2022-07-01 | 2024-01-03 | Labelic Analysis, S.L. | Zusammensetzung zur behandlung von tinnitus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4409144A (en) * | 1978-01-19 | 1983-10-11 | Research Corporation Of The University Of Hawaii | Xeronine, a new alkaloid, useful in medical, food and industrial fields |
US5288491A (en) * | 1992-09-24 | 1994-02-22 | Herbert Moniz | Noni (Morinda Citrifolia) as a pharmaceutical product |
-
2000
- 2000-03-02 SE SE0000698A patent/SE516468C2/sv not_active IP Right Cessation
-
2001
- 2001-03-02 EP EP01912627A patent/EP1261358B1/de not_active Expired - Lifetime
- 2001-03-02 AT AT01912627T patent/ATE286402T1/de not_active IP Right Cessation
- 2001-03-02 DE DE60108227T patent/DE60108227D1/de not_active Expired - Lifetime
- 2001-03-02 AU AU2001241315A patent/AU2001241315A1/en not_active Abandoned
- 2001-03-02 WO PCT/SE2001/000447 patent/WO2001064231A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
SE0000698L (de) | 2001-09-03 |
AU2001241315A1 (en) | 2001-09-12 |
WO2001064231A1 (en) | 2001-09-07 |
DE60108227D1 (de) | 2005-02-10 |
SE516468C2 (sv) | 2002-01-15 |
EP1261358A1 (de) | 2002-12-04 |
EP1261358B1 (de) | 2005-01-05 |
SE0000698D0 (sv) | 2000-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6436449B2 (en) | Use of a composition | |
Diamond et al. | Ginkgo biloba extract: mechanisms and clinical indications | |
ATE299022T1 (de) | Verwendung von cyclopamine zur herstellung eines arzneimittels zur behandlung von psoriasis | |
JP3388117B2 (ja) | カイガンショウ抽出物に基づく血小板反応性調節剤の調製方法 | |
PL1778680T3 (pl) | Spirocykliczne pochodne cykloheksanu | |
DE60026152D1 (de) | Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs | |
TW200612903A (en) | Use of trisubstituted benzopyranones | |
EA200701923A1 (ru) | Лекарственная форма для перорального введения витамина | |
ATE286402T1 (de) | Verwendung von morinda citrifolia zur behandlung von tinnitus | |
ATE372776T1 (de) | Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit | |
WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
ATE309817T1 (de) | Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs | |
ATE275409T1 (de) | Zusammensetzung enthaltend verbindungen mit adrenergischer aktivität und pflanzliche extrakten von crataegus und gingko zur behandlung von übergewicht und fettleibigkeit | |
DE60229240D1 (de) | Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes | |
SE0102887D0 (sv) | New formulation | |
MD2211F1 (en) | Remedy for treatment of parodontium affections | |
TW200626133A (en) | Oral medication for twice-daily administration | |
PL1668021T3 (pl) | Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie | |
ATE261732T1 (de) | Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl | |
DE69936773D1 (de) | Behandlung von depression und zusammensetzungen dazu | |
ATE427108T1 (de) | Anticholinergika enthaltende arzneimittel zur behandlung von krankheiten der ableitenden harnwege | |
RU2004104036A (ru) | Композиция для лечебно-профилактического ухода за кожей и лечения кожных заболеваний | |
ATE493976T1 (de) | Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose | |
PL374841A1 (en) | Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass | |
TH87455B (th) | ผงชนิดแตกตัวในปากซึ่งประกอบรวมด้วยไซโลสทาซอล |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |